Researchers from University College Cork Report New Studies and Findings in the Area of Health Policy (The international generalisability of evidence…

Researchers from University College Cork Report New Studies and Findings in the Area of Health Policy (The international generalisability of evidence for health policy: A cross country comparison of medication adherence following policy change)

By a News Reporter-Staff News Editor at Managed Care Weekly Digest -- Investigators publish new report on Health Policy. According to news reporting out of Cork, Ireland, by NewsRx editors, research stated, "Copayments for prescriptions may increase morbidity and mortality via reductions in adherence to medications. Relevant data can inform policy to minimise such unintended effects."

Our news journalists obtained a quote from the research from University College Cork, "We explored the generalisability of evidence for copayments by comparing two international copayment polices, one in Massachusetts and one in Ireland, to assess whether effects on medication adherence were comparable. We used national prescription data for public health insurance programmes in Ireland and Medicaid data in the U.S. New users of oral anti-hypertensive, anti-hyperlipidaemic and diabetic drugs were included (total n = 14,259 in U.S. and n = 43,843 in Ireland). We examined changes in adherence in intervention and comparator groups in each setting using segmented linear regression with generalised estimating equations. In Massachusetts, a gradual decrease in adherence to anti-hypertensive medications of -1% per month following the policy occurred. In contrast, the response in Ireland was confined to a -2.9% decrease in adherence immediately following the policy, with no further decrease over the 8 month follow-up. Reductions in adherence to oral diabetes drugs were larger in the U.S. group in comparison to the Irish group. No difference in adherence changes between the two settings for anti-hyperlipidaemic drugs occurred. Evidence on cost-sharing for prescription medicines is not 'one size fits all."

According to the news editors, the research concluded: "Time since policy implementation and structural differences between health systems may influence the differential impact of copayment policies in international settings."

For more information on this research see: The international generalisability of evidence for health policy: A cross country comparison of medication adherence following policy change. Health Policy, 2017;121(1):27-34. Health Policy can be contacted at: Elsevier Ireland Ltd, Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ireland. (Elsevier - www.elsevier.com; Health Policy - www.journals.elsevier.com/health-policy/)

Our news journalists report that additional information may be obtained by contacting S.J. Sinnott, Univ Coll Cork, Dept. of Epidemiol & Public Hlth, Cork, Ireland. Additional authors for this research include H. Whelton, J.M. Franklin and J.M. Polinski (see also Health Policy).

Keywords for this news article include: Cork, Ireland, Europe, Health Policy, Legislation, University College Cork.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC